Bioklone Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 36.80%
- Profit Growth 52.12%
- Ebitda 180.02%
- Net Worth -22.82%
- Total Assets -34.46%
About Bioklone Biotech
Bioklone Biotech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2013 and has a history of 11 years and ten months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Theerthanarayana Venkataramani and Krishnamurthy Rajeshwari serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TN2013PTC089991
-
Company No.
089991
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Bioklone Biotech Private Limited offer?
Bioklone Biotech Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Software Development Services, Customized Software Solution, Anti Cancer Medicines, Monoclonal Antibodies, Banking Service, Mobile Banking Services.
Who are the key members and board of directors at Bioklone Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurthy Rajeshwari
|
Managing Director | 12-Mar-2013 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Theerthanarayana Venkataramani
|
Director | 12-Mar-2013 | Current |
Financial Performance of Bioklone Biotech.
Bioklone Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.8% increase. The company also saw a substantial improvement in profitability, with a 52.12% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioklone Biotech?
Unlock access to Bioklone Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Axletree Solutions India Private LimitedTheerthanarayana Venkataramani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioklone Biotech?
Unlock and access historical data on people associated with Bioklone Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioklone Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioklone Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.